Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mission Therapeutics Ltd.

www.missiontherapeutics.com

Latest From Advanced Bionics Corp.

News In Brief

J&J scrutiny continues. New product launches. More news.

New Products In Brief

Recent product approvals and launches

Medical Device

New Avenues in Neuromodulation

Implantable neurostimulation devices have the potential to ameliorate a number of debilitating conditions in which neural pathways play a role. Combined, these applications are expected to bring in device revenues of nearly $1.4 billion in the US alone in 2010, and that number is forecast to increase by double-digits going forward, reaching over $2.6 billion by 2014, according to Medtech Insight's recently published report, "US Markets for Neurostimulation Products."
Medical Device Platform Technologies

Device Incubation: Challenges in Making the Model Work

Device incubators have their proponents and detractors, but remain a constant source of company creation. The big question: is this model sustainable?
Medical Device Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Inflammation
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Mission Therapeutics Ltd.
  • Senior Management
  • Anker Lundermose, MD, PhD, CEO
    David Luther, CFO
    Stephen Jackson, PhD, CSO
    Paul Wallace, PhD, CBO
    Anne Phelan, PhD, Head, Discovery Research
  • Contact Info
  • Mission Therapeutics Ltd.
    Phone: 1223 497454
    Babraham Research Campus, Moneta
    Bldg. 280
    Cambridge, CB22 3AT
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register